IP6K2 predicts favorable clinical outcome of primary breast cancer
Author(s) -
Josefine Sandström,
A. Balian,
Rebecca Lockowandt,
Tommy� Fornander,
Bo Nordenskjöld,
Linda S. Lindström,
G. Pérez-Tenorio,
Olle Stål
Publication year - 2021
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2021.2256
Subject(s) - breast cancer , oncogene , cancer , oncology , biology , pi3k/akt/mtor pathway , protein kinase b , medicine , cohort , molecular medicine , cancer research , gene , gene expression , bioinformatics , cell cycle , apoptosis , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom